DFFN - 1.94 Pre-market now at 2.51/2.69 Diffusion Pharmaceuticals Achieves Drug Production Milestone For Planned Phase 3 Clinical Trial In Inoperable GBM Brain Cancer http://stockcharts.com/c-sc/sc?s=DFFN&p=D&b=5&g=0&i=t25842648537&r=1500554986728 http://stockcharts.com/c-sc/sc?s=DFFN&p=W&b=5&g=0&i=t84681932498&r=1500555005394